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Abstract
Our vision of cancer has changed during the past decades. Indeed tumors are now perceived as complex entities
where tumoral and stromal components interact closely. Among the different elements of tumor stroma the
cellular component play a primordial role. Bone Marrow derived mesenchymal cells (MSCs) are attracted to tumor
sites and support tumor growth. Endothelial cells (ECs) play a major role in angiogenesis. While the literature
documents many aspects of the cross talk between stromal and cancer cells, the role of direct hetero-cellular
contact is not clearly established. Recently, Tunneling nanotubes (TnTs) have been shown to support cell-to-cell
transfers of plasma membrane components, cytosolic molecules and organelles within cell lines. Herein, we have
investigated the formation of heterocellular TnTs between stromal (MSCs and ECs) and cancer cells. We
demonstrate that TnTs occur between different cancer cells, stromal cells and cancer-stromal cell lines. We showed
that TnTs-like structure occurred in 3D anchorage independent spheroids and also in tumor explant cultures. In our
culture condition, TnTs formation occurred after large membrane adhesion. We showed that intercellular transfers
of cytoplasmic content occurred similarly between cancer cells and MSCs or ECs, but we highlighted that the
exchange of mitochondria occurred preferentially between endothelial cells and cancer cells. We illustrated that the
cancer cells acquiring mitochondria displayed chemoresistance. Our results illustrate the perfusion-independent role
of the endothelium by showing a direct endothelial to cancer cell mitochondrial exchange associated to
phenotypic modulation. This supports another role of the endothelium in the constitution of the metastatic niche.
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Background
Tissues are comprised of different cell types that
communicate to maintain homeostasis [1]. While cell
number and positional identity of normal tissues are
lost in cancers, tumor cells keep many interactions with
surrounding non-malignant cells and extra-cellular matrix
[2]. Indeed, primary and metastatic tumors contain a
variety of stromal cell types such as endothelial cells
(ECs), fibroblasts and various bone marrow-derived cells,
including macrophages, mast cells, and mesenchymal
stem cells (MSCs) [3]. These various cell types are
recruited to the tumor site and through the modulation
of different pathways contribute to tumor growth and
metastasis [4-10]. The interaction between cancer and
stromal cells are primordial for the biology of the tumors.
Several lines of evidence have been provided. The
cross talk between cancer cells and fibroblasts induces
phenotypic modification of the stromal cells toward a
Cancer Associated Fibroblasts (CAF) phenotype promoting
in return the cancer cells [11]. In the metastatic context
bone marrow derived cells can be attracted to the site of
metastasis and prepare the metastatic niche [12].
Comforting these findings, Park group has demonstrated
that a signature of the stroma can predict outcome in
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breast cancer patients [13]. Understanding the mechanisms
implicated in the relationship between cancer cells and
stromal cells are thus essential to target tumor progression.
Several mechanisms are involved in the cross talk
between cancer and stromal cells: (i) cytokine/receptor
interaction [8,14] (ii) direct cell contact and material
exchange [15-17] (iii) micro-particle mediated cell
communication [18]. Recently the role of contact-dependent
interactions between cancer and stromal cells has been
emphasized. These are mediated by synapses, GAP
junction and cell-to-cell communication through tunneling
nanotubes (TnTs) [19]. First described in cultured rat
pheochromocytoma PC12 cells [20], TnTs have been
observed in multiple cell types in vitro [21] and more
recently in vivo [22,23]. These thin plasma membrane
structures connecting cells allow intercellular transfers
of organelles, various plasma membrane components
and cytoplasmic molecules [24]; calcium ions, major-
histo-compatibility proteins (MHC class I), pathogens,
small organelles of the endosomal/lysosomal system,
mitochondria and ATP-Binding Cassette transporter
(P-glycoprotein) have all been shown to be transferred
between different cells by TnTs [19,25-29]. While the
importance of TnTs-mediated interaction in vivo is
still debated in the literature due to lack of a specific
inhibitor to tailor their role, there are now evidences
demonstrating the functional role of TnTs-mediated
intercellular transfer [30].
Several studies demonstrate the existence of TnTs
mediated transfers between cancer cells [31]. Thus presence
of TnTs was established using cells derived from patient
specimens as well as from established cancer cell lines.
Different components are transferred through TnTs.
However the role of TnTs in forming direct cytoplasmic
connections between cancer and stromal cells and their
consequences remains to be established.
In this study, we hypothesized that TnTs could mediate
cytoplasmic exchange and phenotype transfer between
stromal and cancer cells. In our culture conditions we
observed TnTs, established between different cancer cells
(breast and ovarian cancer cell lines) and stromal
cells (mesenchymal stem cells and endothelial cells).
We described spontaneous exchange of cytoplasmic
material between ECs or MSCs and multiple cancer cell
lines. We showed a preferential transfer of mitochondria
from endothelial to cancer cells resulting in acquisition of
chemoresistance. Thus, our results raise the possibility of
direct intercellular exchange as a modulator of tumor
phenotype by the stromal component.
Experimental procedures
Cell culture
Ovarian cancer cells lines SKOV3 (HTB-77), OVCAR3
(HTB-161), breast cancer cell lines MDA-MB231 and
MCF7 were purchased from the American Type Culture
Collection (ATCC, Manassas, VA, USA). Cells were grown
in DMEM high glucose (Hyclone, Thermo Scientific)
supplemented with 20% FBS (Hyclone, Thermo Scientific),
1% Penicillin-Streptomycin-Amphotericyn B solution
(Sigma), 2 mM L-glutamine (Sigma), 1X Non-Essential
Amino-Acid (Hyclone, Thermo Scientific).
The E4ORF1+ ECs (E4+ECs) were generously provided
by Shahin Rafii [32]. The cells were grown in M199
(Gibco, Life Technologies) supplemented with 20% FBS,
1% Penicillin-Streptomycin-Amphotericyn B solution
(Sigma), 4 mM L-glutamine, 50 μg/ml heparin (Sigma)
and 30 μg/ml β EC growth factor (βECGF, Upstate
Biotechnology, Lake Placid, NY, USA). These cells
express green fluorescence protein (GFP).
Mesenchymal stem cells (MSCs) were purchased from
Stem Cells, Inc (MSC-001 F, Vancouver, CA) maintained
and expanded in culture using MesenCultW MSC Basal
Medium completed with Mesenchymal Stem Cell
Stimulatory Supplements (Stem Cell Inc, Vancouver, CA).
Their ability to differentiate in adipocytes, osteoblasts and
chnodrocytes was verified as instructed by the supplier
(data not shown). All cultured cells were incubated
at 37°C under a water-saturated 95% air-5% CO2
atmosphere. Shaking cultures were performed similarly
using a rocking plates at low speed.
Sphere formation
Cells were dissociated into single cell suspension by
trypsinization and further sieving through 40-um cell
strainers and subsequently resuspended in 3D media
containing DMEM F-12 supplemented with 2% B27
(Invitrogen), 20 ng/mL VEGF (Peprotech), 20 ng/mL
bFGF (Peprotech), and 5 ug/mL insulin (Sigma). The
cells were plated at 5000 cells per well of ultralow
attachment 24-well plates (Costar, Corning) and were
grown in a humidified incubator at 37°C and 5% CO2.
The media was changed every second day. Primary
spheres started to form at day 3 and continued to be
cultured for up to 5 days.
Explant culture
Tumor material from patients presenting advanced ovarian
carcinoma Stage IIIC were included in this study (IRB
Number: #9161/2010, “Isolation and characterization of
cancer stem cells”). During debulking surgery metastatic
nodules were removed and processed as follows. Upon
serial washing with PBS and red blood cell Lysis
buffer (eBiosciences, San Diego, USA) nodules were
minced and cultured with or without feeders (EC+E4)
in DMEM high glucose (Hyclone, Thermo Scientific)
supplemented with 20% FBS (Hyclone, Thermo Scientific),
1% Penicillin-Streptomycin-Amphotericyn B solution
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(Sigma), 2 mM L-glutamine (Sigma), 1X Non-Essential
Amino-Acid (Hyclone, Thermo Scientific).
Labeling of cell organelles
To trace intercellular exchange of mitochondria, cells
were separately labeled with MitoTracker DeepRed and
Green (Invitrogen) according to the manufacturer’s protocol
[26]. Briefly, cells were resuspended in prewarmed (37°C)
staining solution containing the MitoTrackerW probe
(50 nM) for 30 minutes under growth conditions appro-
priate. After staining, cells were washed 3 times in PBS
and resuspended in fresh prewarmed medium. Cells were
plated in mono or co-culture according to the experiment.
Confocal microscopy
Live-cell TnTs imaging using previously published
protocols was performed [20]. Cells were labeled with
1 mg/ml Alexa FluorW 594 conjugated wheat germ
agglutinin (WGA, Invitrogen SARL, Cergy Pontoise,
France) at 5 μg/ml for 10 minutes at 37°C in the
dark. WGA is a probe for detecting glycoconjugates,
which selectively bind to N-acetylglucosamine and N-
acetylneuraminic acid residues of cell membranes.
Imaging was performed using a Zeiss confocal Laser
Scanning Microscope 710 (Carl Zeiss). Post-acquisition
image analysis was performed with Zeiss LSM Image
Browser Version 4.2.0.121 (Carl Zeiss).
Microparticle purification
MPs from eGFP-E4+ECs were isolated as previously
described [16]. Briefly, 48-h-supernatants of 80% serum-
starved confluent tumor or endothelial cells were
collected and sequentially centrifuged (4°C) at 300 g for
10 min, 800 g for 10 min, and at 3000 g for 15 min. MPs
were pelleted at 100,000 g for 1 h, and washed once in
PBS and centrifuged again at 100,000 g for 1 h. The
final pellet containing purified MP was labeled with
MitoTracker DeepRed to assess mitochondria transfer by
microparticles.
Analysis of transfer by flow cytometry
After co-culture, cells were trypsinized, resuspended and
washed with PBS. Fluorescence (FL) was quantified on a
SORP FACSAria2 (BD Biosciences). Data were processed
with FACSDiva 6.3 software (BD Biosciences). Doublets
were excluded by FSC-W x FSC-H and SSC-W x SSC-H
analysis; eGFP fluorescence was acquired with 488 nm
blue laser and 510/50 nm emission, Mitotracker Deep
Red was acquired with 640 nm red laser and 670/14 nm
emission. Figures display the median of fluorescence
intensity (mfi) relative to control. Single stained channels
were used for compensation and fluorophore minus one
(FMO) controls were used for gating. 20,000 events were
acquired per sample.
Cell viability study (MTT assay)
Viability of cells was examined with an MTTassay. 24 hours
after treatment with doxorubicin, 10% of MTT reagent was
added to each well to a final concentration of 500 μg/ml,
and the cells were incubated for 4 hours at 37°C. 100 μl of
DMSO were added to each well. Optical density was read
at 570 nm versus 630 with an EnVision multilabel reader
(PerkinElmer, Massachusetts, USA). 3 triplicates were
performed per condition.
Statistical analysis
All quantitative data are expressed as mean ± standard
error of the mean (SEM). Statistical analysis was performed
using SigmaPlot 11 (Systat Software Inc., Chicago, IL). A
Shapiro-Wilk normality test, with a p = 0.05 rejection
value, was used to test normal distribution of data prior to
further analysis. All pairwise multiple comparisons were
performed by one way ANOVA followed by Holm-Sidak
posthoc tests for data with normal distribution or by
Kruskal-Wallis analysis of variance on ranks followed by
Tukey posthoc tests, in case of failed normality test. Paired
comparisons were performed by Student’s t-tests or
by Mann–Whitney rank sum tests in case of unequal
variance or failed normality test. Statistical significance
was accepted for p < 0.05 (*), p < 0.01 (**) or p < 0.001 (***).
All experiments were repeated at least three times.
Results
Homocellular and heterocellular TnTs occur
spontaneously in various cancer cell cultures
Previous studies reporting the occurrence of TnTs
in vitro mainly focus on a specific cell types. Here we
determined the presence of TnTs between various cancer
and stromal cells under the same culture conditions. Four
cancer cell lines were assessed (MCF7 and MDA derived
from breast cancers, and SKOV3 and OVCAR3 derived
from ovarian cancers). Homo-cellular TnTs were observed
in all cancer cell lines studied (Additional file 1: Figure
S1A). Similarly TnTs were also found in non-malignant
E4+ECs and MSCs (Additional file 1: Figure S1B-C). To
study the role of TnTs in interactions between stromal
and cancer cells, M-Orange-MSCs and eGFP-E4+ECs
were co-cultured with different cancer cells. TnTs were
found connecting cancer cells and M-Orange-MSCs or
eGFP-E4+EC (Figure 1A-B).
All observed structures displayed the specific charac-
teristics of TnTs: (i) they had no contact to the substratum
and hover in the extracellular medium (Additional file 1:
Figure S2A to C, Additional file 2: Movie 1) (ii) they
exhibited a typical width of less than 0.5 μm and a
length over several cell diameters (Additional file 1:
Figure S2D-E), (iii) they contained F-actin (Additional
file 1: Figure S2F).
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We then studied explants from ovarian cancer metastatic
nodules to test whether TNTs could occur in a tumor
context. We cultured these in a 3D setting and were able
to visualize TnTs-like structures at the periphery of the
explants (Figure 1C and Additional file 1: Figure S3A).
Recently there has been an emphasis on other cell culture
conditions such as spheroid formation assay. These are
performed in low-adherent culture plates and consist
in the formation of floating cellular aggregates that
evolving in cell spheroids. We therefore assessed the
occurrence of TnTs in a 3D anchorage independent
spheroid co-culture system. Confocal microscopy
A B
C D
E
Figure 1 Hetero-cellular Tunneling NanoTubes (TnTs) connect stromal to various tumor cells in culture. A, confocal imaging of TnTs in
co-culture system. Different tumoral cell lines were co-cultured with eGFP-E4+ECs. Before imaging by confocal microscopy, the co-cultures were
stained with Alexa Fluor 594 conjugated-wheat germ agglutinin (WGA AF594) to reveal cell membranes. Hetero-cellular TnTs can be observed
between eGFP-E4+ECs in each of the four cell lines studied (MCF7 top left panel, MDA top right panel, SKOV3 bottom left panel, OVCAR3 bottom,
right panel). Scale bar: 5 μm. B, confocal imaging of TnTs in co-culture system. MDA, OVCAR3, SKOV3 or MCF7 cells were stained with CellTracker
Green, mixed 1/1 with, M-orange-stained Mesenchymal Stem Cells (MSCs) and plated on glass coverslips for subsequent co-cultures. Before
imaging, membranes of the co-cultured cells were stained with WGA AF594. Representative images of hetero-cellular TnTs connecting MDA,
OVCAR3, SKOV3 or MCF7 cells TnTs to MSCs are presented. Scale bar: 10 μm. C, Phase contrast imaging of ovarian cancer explant. Explants of
metastatic ovarian cancer nodules were cultured during ten days in Petri dishes (top left panel). Cells spreading from 3D explants (bottom left
panel). TnTs-like structures with high length-to-diameter ratios bridged cells (cell 1 to cell 2 in the right panel). D, confocal imaging of 3D cultures.
Angiospheres containing MDA and eGFP-E4+ECs were grown in 3D media for three days and stained with WGA AF594. TnT can be identified between
cancer cells in fluorescence (left panel) and in transmission (right panel) in distinct sphere formations. Scale bar: 10 μm. E, confocal imaging of 3D
cultures. Angiospheres containing SKOV3 and eGFP-E4+ECs were grown in 3D media for three days and stained with WGA AF594. TnT connecting
cancer cells and eGFP-E4+ECs can be observed. Z-X reconstitution shows TnT typical no attachment to the substrate. Scale bar: 10 μm.
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Figure 2 Time-lapse studies of TnTs formation. A, detailed frames extracted from time-lapse recording of the movie 2. This event happened
at 43 seconds in the left corner of movie 2. Duration was reported, 38 min 42 second in total. This set of pictures allows us to see formation
of a TnT by membrane projection between MCF-7 and MSCs co-cultured for 24 hours. Scale bar: 10 μm. B-C, detailed frames extracted from
time-lapse recording of the movie 2. This event happened at 1 min 10 seconds in the left top corner (B) and at 1 min 12 seconds on the right
top corner (C). Duration was reported, 49 min 32 seconds (B) and 2 hours 42 min (C). Serial images showing the formation of a nanotube
following large membrane adhesion between MCF-7 and MSCs Scale bar: 20 μm. D, Detailed frames extracted from time-lapse recording of the
movie 5. MCF-7 and eGFP-E4+ECs were co-cultured and stained using WGA AF594 to reveal cell membranes. Separated cells migrated toward
each other. After the contact lasting the two cells formed nanotubes (arrows) elongating as the cells separated further. Scale bar: 10 μm.
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imaging of three days-old mixed spheres (stromal-cancer
cells) displayed TnTs between: (i) cancer cells, (ii) cancer
and stromal cells (Figure 1D and E and Additional file 1:
Figure S3B and C).
Formation of TnTs
Several models have been proposed for the formation
of TnTs, mainly describing the connection between
projections of two cell membranes [30,33]. We observed,
in our culture conditions, such projections of TnTs
between two cells (Figure 2A and Additional file 3:
Movie 2). However, using time-lapse studies, we mainly
observed the following succession of events: cell
migration, large intercellular adhesion, cell separation,
occurrence and/or persistence of TnTs, disruption of
TnTs as the cells separated further (Figure 2B-D and
Additional file 3: Movies 2, Additional file 4: Movie 3,
Additional file 5: Movie 4 and Additional file 6:
Movie 5). This emphasizes the role of large membrane
adhesions before the formation of TnTs.
TnTs mediate preferential transfer of cytoplasmic
components from stromal cells to cancer cells
We used co-culture experiments to investigate a potential
exchange of cytosolic content through TnTs. In many
instances, we observed TnT-mediated transfer of GFP
or M-Orange between cancer and stromal cells. Then,
our time-lapse studies confirmed specific movement of
dyes along a nanotube suggesting cytoplasmic components
transfer from stromal to cancer cells (Figure 3A-B,
Additional file 7: Movie 6 and Additional file 8: Movie 7).
During phase contrast microscopy analysis, punctual
densities were also observed, potentially corresponding to
subcellular organelles (Figure 3C-D, Additional file 3:
Movie 2). Nanotube mediates transfer of mitochondria
between endothelial and endothelial progenitor have been
previously described [34]. Therefore, we subsequently
investigated the transfer of eGFP-E4+ECs mitochondria to
cancer cells using the organelle-specific dye Mitotracker.
Stained mitochondria could be visualized in the TnTs
connecting eGFP-E4+ECs to various cancer cells (Figure 4A).
Confocal time-lapse imaging demonstrated transfer of
A B
C
D 00:00:00 00:06:32 00:13:21
00:22:02 00:27:38 00:34:53
MCF7
MDA
SKOV3
OVCAR3
Figure 3 Intercellular transfer of cytoplasmic contents through TnTs. Tumoral cells were co-cultured with eGFP-E4+ECs or M-Orange-MSCs.
Before imaging by confocal microscopy, the co-cultures were stained with WGA AF594 to reveal cell membranes. Confocal imaging showed
hetero-cellular TnTs containing GFP (A) or M-Orange (B). WGA-stained cytoplasmic content were also seen at several points in TNTs (C, arrows).
Subsequently GFP or M-Orange could be observed in recipient cancer cells in different panels. A, GFP dots (arrows) could be observed in
recipient cells in different panels (MCF7 on the top, MDA on the center, SKOV3 on the bottom) Scale bar: 10 μm. B, M-orange could be detected in
recipient OVCAR3 cancer cells. Scale bar: 20 μm. C, Scale bar: 10 μm. D, detail frames extracted from time-lapse recording of the movie 2. This
event happens at 55 seconds in the left side of movie 2. Duration was reported, 34 min 53 second in total. Cytoplasmic material was transferred
through TnTs as indicated (arrow). Scale bar: 10 μm.
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mitochondria stained by Mitotracker (Figure 4B and
Additional file 9: Movie 8). We also investigated the
transfer of eGFP-E4+ECs mitochondria to tumor explants.
Indeed, we cultured ovarian cancer tumor explants on
eGFP-E4+ECs feeder stained with Mitotracker-Red.
After 48 h of culture, tumor explants were removed and
confocal analysis showed uptake of eGFP-E4+ECs mito-
chondria (Figure 4C).
To investigate whether organelle transfer displayed cell
specificity MCF7 and eGFP-E4+ECs or M-Orange-MSCs
A
B
C
Phase contrast microscopy 
of a tumor explant on an E4 feeder
00:00:00 00:17:40 00:22:04
00:35:19 01:01:49 01:23:54
Confocal microscopy  of a  tumor explant (lower section) 
Phase contrast Mitotracker
Figure 4 Transfer of Mitochondria between eGFP-E4+ECs and cancer cells. A, confocal images of mitochondria transfer through TnTs.
eGFP-E4+ECs were stained with MitoTracker Deep-Red to follow their mitochondria. Subsequently, they were co-cultured with cancer cells. Prior
to confocal imaging, co-cultures were stained with WGA AF594 to reveal cell membranes. We identified transfer of mitochondria through TnTs
from eGFP-E4+ECs to cancer cells (MCF7 right panel, MDA left top panel, OVCAR3 and SKOV3 left bottom panels). MitoTracker staining could also
be observed in cancer cells cytoplasm. Scale bar: 10 μm. B, detailed frames extracted from movie 8, WGA staining shows the presence of a TnT
(left panel), Mitotracker stained material transfer can be observed within the TnT (right panel) C, phase contrast imaging of ovarian cancer explant
on eGFP-E4+ECs layer. eGFP-E4+ECs were stained with MitoTracker Deep-Red. Tumor explants were cultured on a feeder of eGFP-E4+ECs stained
with Mitotracker (Let panel, scale bar: 500 μm). Confocal imaging were performed after 48 hours of culture. Mitochondria from eGFP-E4+ECs were
observed within the tumor explant (Middle and right panel, scale bar: 100 μm).
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Figure 5 Preferential exchange of mitochondria from eGFP-E4+ECs to MCF-7. A, confocal imaging of co-cultures between MCF7 and
eGFP-E4+ECs. Prior to co-culture, eGFP-E4+ECs were tagged with MitoTracker Deep Red. After 48 hours, co-cultures were stained with WGA AF594
to reveal cell membrane. eGFP-E4+ECs mitochondria could be detected in MCF7 (dotted squares). Scale bar: 20 μm. B, Similar experiments were
performed with M-orange-MSCs. No exchange was detected at ratio 1/1. Scale bar: 20 μm. C, Tri-culture of MCF7, MSCs (stained with MitoTracker
Green) and non-GFP E4+ECs (stained with MitoTracker Red) were performed. After 48 hours, cultures were stained with WGA-AF594. E4+ECs
mitochondria (blue) were detected in MCF7 and MSCs, while MSCs mitochondria (green) remained restricted to MSCs in this set-up. Scale bar:
20 μm. D, Flow cytometry plot of different ratio of co-culture of eGFP-E4+ECs/MCF7. Prior to co-culture eGFP-E4+ECs were stained with
MitoTracker DeepRed. The number of MCF7 up-taking mitochondria from eGFP-E4+ECs increased in relation to the number of eGFP-E4+ECs.
E, graphical representations of the flow cytometry findings.
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Figure 6 Transfer of mitochondria from eGFP-E4+ECs to MCF7 confers chemoresistance. A, Flow Cytometry Scatter plot showing the
gating strategy for definition of the different cell-populations subjected to cell sorting. B, Confocal imaging post-sorting. Mt+MCF7 displayed
Mitotracker staining (top left panel) and GFP+MCF7, GFP staining (top right panel) however Mt-MCF7 did not display Mitotracker nor GFP staining
(bottom panel). Scale bar: 10 μm. C, MTT assay after doxorubicine treatment was performed on sorted cells. Mt+MCF7 population (red) displayed
significantly increased chemoresistance compared to other control populations. However compared to controls, Mt-MCF7 (black) or GFP+MCF7
(green) displayed also chemoresistance (10 μM doxorubicine). (p < 0.05 (*), p < 0.01 (**) or p < 0.001 (***)). D, Cell viability was assessed for
Mt+MCF7, Mt-MCF7 and control MCF7 treated by 10 μM doxorubicine using Live/Dead Invitrogen kit (calcein AM and ethidium homodimer-1).
Mt+MCF7 displayed chemoresistance. Experiments were performed in triplicate.
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co-cultures were established and mitochondria transfer
from stromal cells was monitored. TnTs seemed similarly
distributed among cell types. However, at a ratio of 1
MCF7 /1 stromal cell, only endothelial cells were able
to transfer mitochondria to MCF7s (Figure 5A-B).
MSCs mitochondria transfer to cancer cells could only
be visualized using an increased ratio (1/10) of MCF7/
MSCs (Additional file 1: Figure S4). We then established
a tri-culture system (MCF7, MSCs and E4+ECs). TnTs
were observed between all different cell types, however,
in this setting, MCF7 only acquired E4+ECs mitochondria
(Figure 5C). We could also detect uptake of E4+ECs
mitochondria by M-Orange-MSCs. Our data provided
evidence for a preferential transfer of mitochondria from
endothelial cells under our culture conditions.
One of the most common criticisms of such experiment
is the ability of the dyes to diffuse. Several findings argued
against such bias. The presence of MCF7 cells with
different level of Mitotracker after 48 hours of co-culture
argued against passive dye transfer. In our tri-culture
set-up, the preferential transfer ruled out the possibility
of passive diffusion. Indeed it is quite unlikely that dyes
would only leak form one cell type. Switching dyes used
between E4+ECs and MSCs did not modify these findings
(data not shown). Flow cytometry evaluation of mitochon-
dria uptake at different ratio of eGFP-E4+ECs/MCF7
ranging from 1/1 to 1/10 demonstrated that exchange of
mitochondria was related to the number of stromal cells
(Figure 5D-E).
Among other mechanisms involved in the cross-talk
between cancer et stromal cells, microparticles (MPs)
have been involved in the transfer of organelle [35]. We
investigated the implication of MPs in the transfer
of mitochondria between endothelial and cancer cells.
We stained MPs extracted from eGFP-E4+ECs using
Mitotracker. While cancer cells were able to uptake
endothelial MPs, the uptake of mitochondria by MCF7
through MPs was negligible (Additional file 1: Figure
S5A-B). Similar results were obtained if endothelial cells
were stained before MPs isolation. This indicated that
mitochondria transfer from eGFP-E4+ECs under our cell
culture conditions did not occur through microparticles.
We also used a transwell experiment setting to confirm the
role of direct cell contact in the transfer of mitochondria.
Confocal and flow cytometry analysis could not detect any
Mitotracker-Red uptake in the transwell experiments
(Additional file 1: Figure S6A-B). In order to rule out the
possibility that diffusing Mitotracker into the medium
could be adsorbed by the filter of the transwell chambers,
we seeded MCF7 on the bottom or the top of the
transwell chamber and mitotracker on the other side. Flow
cytometry showed constant staining of MCF7 suggesting
that passive diffusion could occur through the membrane
(Additional file 1: Figure S6C). Finally shaking cultures
that do not allow the formation of TnTs were performed
[36]. Under these conditions no Mitochondria transfer
was observed compare to controls (Additional file 1:
Figure S7). These experiments excluded the possibility of
massive dye transfer and strongly suggested that TnTs
participated to mitochondria transfer.
Acquisition of mitochondria leads to the emergence of a
chemoresistant phenotype
Mitochondria transfer between two cells have been
associated to phenotypic modification [37], however a
direct functional benefit of TnT mediated material
exchange has not yet been demonstrated in the cancer
setting. We hypothesized that MCF7 acquiring endothelial
mitochondria would display greater chemoresistance.
We previously described TnT mediated transfer of
P-glycoprotein from resistant to sensitive cells [29]. We
first verified that both eGFP-E4+ECs and MCF7 did not
express ABCB1 (Data not shown).
To assess functional gain, fluorescence minus one
was used to set up the cell-sorting gate as stringent as pos-
sible (Figure 6A). Cells having acquired eGFP-E4+ECs
mitochondria (Mt+MCF7, red) and cells did not acquire
any mitochondria (Mt-MCF7, black) were sorted. Mt-
MCF7 population allowed us to control for other factors
such as endothelial secreted factors or direct cell to
cell contact without mitochondria transfer. We finally
sorted cells having only acquired cytoplasmic (excluding
mitochondria) content represented by the GFP+MCF7
population (green). We controlled the purity of our cell
sorting by confocal microscopy (Figure 6B) and subjected
the different cell populations to a MTT viability assay in
presence of doxorubicin; MCF7 cells were used as a
control (grey) (Figure 6C). Mt-MCF7 and GFP+MCF7
displayed chemoresistance (from 1.31 to 1.89 fold
compare to MCF7 control). However MCF7 having ac-
quired eGFP-E4+ECs mitochondria (Mt+MCF7) displayed
significantly more chemoresistance compared to MCF7
control (1.91 to 3.19 fold, p < 0.05). These results
were confirmed using LiveDead staining (Figure 6D).
These experiments indicated that while co-culture and
transfer of cytoplasmic content induced chemoresistance,
the acquisition of mitochondria significantly increased
chemoresistance of MCF 7 to doxorubicin.
Discussion
In this study, we reported spontaneous TnTs mediated
heterocellular exchange between cancer and stromal
cells. We demonstrated TnTs formation in different
cancer cell types, as well as in two types of stromal cells
highly involved in tumor progression. These findings
support that TnTs formation are ubiquitous. The occur-
rence of TnTs in 3D tumor explants is concordant with
the presence of TnTs in tumors previously described in
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human malignant pleural mesothelioma [38]. More
interestingly we showed, for the first time TnTs in
cancer spheroids, which might be a better model to
represent tumor biology and inter-cellular interaction
than classical 2D cultures [39].
TnTs between cancer cells and stromal cells had all
canonical characteristics previously described [20,24].
Time-lapse studies illustrated that TnTs formation is a
common feature and appears to be a dynamic process.
We highlighted the primordial role of large cell adhesion
domain in the occurrence of TnTs. Thus the formation of
TnTs could be consequent to receptor-ligand interaction
and exchange of cellular organelles might be dependent
of the location and/or nature of initial membrane
interaction.
In our different cell culture settings, we demonstrated
transfer of cytoplasmic content from stromal to cancer
cells. Both MSCs and ECs exchanged cytoplasmic materials
with cancer cells without noticeable differences between
the cell types. The transfer of cytoplasmic material between
similar cell types has been described [30]. Recently some
groups have illustrated such phenomena in a heterocellular
context [25,37]. We actually observed also transfer of
cytoplasmic material form cancer to stromal cells, however
the precise significance of this phenomenon is not
addressed in this study.
We provided evidence for mitochondrial transfer between
stromal and cancer cells through TNTs inducing phenotype
modulation. While exchange of cytoplasmic materials
appears to happen similarly for MSCs/CCs and E4+EC/
CCs interactions, we found preferential mitochondria
transfer between cancer and endothelial cells in a
tri-culture system. We carefully addressed the possibility
of leakage and passive diffusion of the dye as follow: (i) we
performed cell culture under shaking condition which
prevents the formation of TnTs and demonstrated no
transfer, (ii) the tri co-culture experiments showed
preferential transfer from endothelial toward cancer cells
with two different dyes, (iii) in the transwell experiment
there was no uptake of mitochondria from the endothelial
cells, (iv) Mitotracker used in similar concentration than
the one used to stain E4+EC was able to cross the
membrane of the transwell system and stain cancer cell
mitochondria, (v) and finally we were able to follow
mitochondria transfer in TnTs by time lapse studies.
Using a 3D explant system, we demonstrated that tumor
cells of ovarian cancer metastatic nodules could uptake
mitochondria from an endothelial cell feeder, suggesting
that in dense cellular environments such structures could
mediate cell-to-cell communications.
Our analysis of different stromal cell lines pointed out
the preferential transfer of mitochondria from endothelial
cells compare to MSCs under our culture conditions. This
supports the existence of a specific process mediating
such exchanges. The specificity of cargoes transferred has
already been illustrated without a precise mechanism,
however structural components, specific signaling pathways
and/or culture conditions may all play a role [40].
Mitochondria transfer has already been described in
different homo- and heterocellular models such as endo-
thelial progenitors and cardiomyocytes [25], astrocytes
[41], primary human renal epithelial cells [42], vascular
smooth cells and MSCs [37], human retinal pigment
epithelial cells [43] and between human malignant
pleural mesothelioma cells [38]. Among these studies,
only one associated a functional gain via TnT dependent
mitochondria exchange. Indeed, Vallabhaneni et al.
demonstrated that vascular smooth muscle cells initiate
proliferation of mesenchymal stem cells through exchange
of mitochondria via TnTs in cocultures [37]. Here, we
illustrated the phenotypic advantage of mitochondria
uptake. Using a cell sorting strategy controlling for
secreted factors, cytoplasmic transfer or cell-to-cell
contact, we showed that cells acquiring mitochondria
displayed significantly chemoresistance. Functional bene-
fits (survival and resistance to stress) from acquisition of
mitochondria have been documented. Spees et al. showed
that active transfers of mitochondria could rescue aerobic
respiration in cells with dysfunctional mitochondria [44].
They indicated that genetic defects in mitochondria DNA
could be rescued by uptake of normally functioning
mitochondria from wild-type cells ex vivo. Oliva et al.
described the role of increased mitochondrial activity
resulting in decreased reactive oxygen species production
and in acquisition of chemoresistance in gliomas [45].
Our study is the first reporting chemoresistance linked to
mitochondria uptake in a heterocellular context.
Chemotherapy mostly aims at directing specifically
cancer cells into apoptosis. Apoptosis is a complex
multi-step mechanism. However mitochondrial membrane
permeability is a primordial step of apoptosis. Classical
anticancer agents such as etoposide, doxorubicin, cisplatin,
or paclitaxel (Taxol) cause indirect mitochondrial
permeability as they trigger apoptosis by inducing p53
expression; activation of the ceramide/GD3 pathway;
by inducing the CD95/CD95L ligand system, affecting
Bcl-2- like proteins; and/or by compromising the
redox or energy balance [46,47]. Proteins of the Bcl family
mediate stabilization of mitochondrial membrane thus
preventing apoptosis. Our discovery of mitochondrial
transfer from the microenvironment to tumor cells raises
questions about tumor cell response to DNA-damaging
anticancer drugs.
We acknowledge that other mechanisms might be
implicated in conferring chemoresistance such as transfer
of other cytoplasmic components (proteins, genetic
material), or transcriptome modifications and this will be
addressed in further studies.
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The presence of TnTs in vivo has been clearly established
in the context of developmental biology (between dendritic
cell in the mouse cornea [22]; Epithelial Cells in Live
Drosophila Wing Imaginal Discs [48]) or neoplasia
(mesothelioma tumor biopsies [38]). Their role in different
cellular functions ranging from transmission of prions
[28,49,50] or virus particles [27,51], electrical coupling
[33,52] cell death signaling [53] to chemoresistance
acquisition through P-Glycoprotein transfer [29], points
out the importance of such physiological process in
multicellular organisms.
Many studies point out the importance of cellular contact
in mediating tumor phenotype modulation [17,29,54,55].
There are evidences in the literature that relative cellular
position in a multicellular context modulate phenotype.
Indeed we have previously illustrated that the Hemato-
poietic Stem cells reside next to a sinusoidal endothelial
niche in the bone marrow [56]. While many local factors
(cytokines, membrane bound) certainly play a role, contact
mediated phenotypic transfer has a role in specific
contexts. The chemoresistance provided by the transfer of
mitochondria can lead to the emergence of a residual
microscopic disease through dynamic phenotype modula-
tion. This emphasize the role of a metastatic niche where
the endothelial-tumor cell contact dependant interaction,
among other mechanisms, could protect few cancer cells
from chemotherapeutic cytotoxicity [57]. Our co-culture
experiment and differential sorting strategy revealed the
occurrence of phenotypic heterogeneity relying on the
interaction between cancer cells and stromal cells.
There are many aspects that need to be investigated:
understanding the mechanisms underlying (i) the specificity
of cell exchange (ii) the constitution of TNTs post-
adhesion and (iii) the role of newly acquired mitochondria
in the phenotype modification of cancer cells as targeting
mitochondria might be a valuable approach in cancer
treatments [58].
All together our comprehensive approach points out the
importance of TnTs in cross-talk between cancer cells
and stromal cells and underlines specificity of such a
physiological process. The role of TnTs mediated commu-
nication needs to be considered in the context of other
cell-to-cell interactions (secreted factors, microparticles,
direct cell contact). Tailoring the importance of such
mechanisms will lead to a better understanding of tumor
dynamics and to design new therapeutic approaches.
Ethics
IRB was obtained at Hamad Medical Corporation.
Additional files
Additional file 1: Figure S1. Intracellular bridges are present in
monocultures of cancer cells, endothelial cells and MSCs. Confocal imaging
of cancer cells (A) or eGFP-E4+ECs (B) or M-orange-MSCs
(C) stained with WGA AF594. Homo-cellular TnTs connections can be
observed between the different cells used in this study A, Scale bar: 10 μm.
B, Scale bar: 20 μm. C, Scale bar: 10 μm. Figure S2. TnTs displayed canonical
features. Alexa Fluor 594 conjugated-WGA-stained cells were analyzed by
live cell confocal microscopy. Observed TNTs were submitted to Z-stack
analysis (A-B). TNTs were not in contact with the substratum. C, Surface
rendering (Imaris) illustrating the independency of the TNTs from the
substratum (MCF7). D-E, TnTs have a diameter smaller than 0.5 μm and a
length of up to several cell diameters. Scale bar: 20 μm. F, Fixed cells were
stained with WGA, DAPI and AlexaFluor 647 conjugated-phalloidin. Merged
images display co-localization of WGA and TRITC-phalloidin staining,
indicating that F-actin is a component of TNTs. Scale bar: 10 μm. Figure S3.
TnTs connect cells in tumor explants and within spheroids. A, Ovarian
cancer explants were cultured for 10 days. TnT-like structures were detected
in the migrating cells of the explant. Cytoplasmic materials could be
observed inside the TnTs-like structure (arrows). Scale bar: 20 μm. B-C,
OVCAR3 or MCF7 were grown in spheroid with eGFP-E4+ECs in 3D media
on low adherent plates. After 3 days, spheroids were stained with WGA-
AF594. TnTs-like structures were detected connecting cells within spheroid
structures. (PDF 776 kb) Scale bar: 10 μm. Figure S4. Mitochondria are
transferred through TnTs between MSCs and Cancer cells. A-C, Co-culture of
M-Orange-MSCs stained with MitoTracker DeepRed and MCF7 at a ratio of
10/1 were performed. Transfer of mitochondria between MSCs and cancer
cells could be observed. Scale bar: 20 μm. C, Cancer Cells with different
amount of mitochondria uptake could be observed suggesting active dye
transfer. Scale bar: 20 μm. Figure S5. Microparticles do not mediate
mitochondria transfer. Microparticles were extracted from eGFP-E4+ECs and
stained with WGA AF594 (A) or MitoTracker Red (B). MCF7 were incubated
with the stained microparticles for 24 hours. MCF7 were able to uptake
microparticles from eGFP-E4+ECs (B) there was, however, negligible
microparticle-mediated passage of mitochondria from
eGFP-E4+ECs to MCF7. Scale bar: 10 μm. Figure S6. Transwell experiments.
A-B, eGFP-E4+ECs were stained with MitoTracker DeepRed. MCF7 and
stained eGFP-E4+ECs were co-incubated in a transwell system. No
mitochondria exchange could be detected neither by confocal microscopy
(A) nor flow cytometry (B). Scale bar: 20 μm. C, MCF7 cells were stained by
MitoTracker DeepRed through a transwell membrane compare to controls
(middle plot: MCF7 plated on the upper side of the transwell, right plot: at
the bottom of the membrane). Transwell experiment demonstrating the
ability of the Mitotracker dye to stain the MCF7 cells through the transwell
system in different settings. Figure S7. Shaking culture abrogates the
transfer of mitochondria from Endothelial to cancer cells. MCF7 (grey) were
co-culure in normal or shaking conditions with eGFP-E4 + ECs (black)
stained with Mitotracker DeepRed. While there was a gain of Mitotracker by
MCF7 in control set-up (red) no transfer could be observed during
shaking (dash red).
Additional file 2: Movie 1. Surface rendering of MCF7 cells
interconnected by TnTs. Surface rendering of Z-stack confocal imaging of
MCF7 with IMARIS software.
Additional file 3: Movie 2. TnTs appear spontaneously in co-culture
between MCF7 and MSC. 6 hours after plating, co-culture of MCF7 and
MSCs were imaged by time-lapse microscopy. The movie sequence was
acquired during 24 hours.
Additional file 4: Movie 3. Formation of TnTs after large membrane
adhesion between ovarian cancer cells. SKOV3 cells were analyzed by
confocal microscopy time-lapse imaging. Cells were stained with WGA-AF594
to reveal the membrane (red). The movie sequence represents 1 hour of
acquisition. Formation of TnTs after large membrane adhesion are observed.
Additional file 5: Movie 4. Formation of TnTs after large membrane
interaction between eGFP-E4 + ECs and breast cancer cells. Co-culture of
MDA and eGFP-E4+ECs (green) cells was stained with WGA-AF594 to reveal
the membrane (red). Stained co-culture was analyzed by confocal microscopy
time-lapse imaging. The movie sequence represents 1 hour of acquisition.
Additional file 6: Movie 5. Formation of TnTs after membrane
interaction between eGFP-E4 + ECs. eGFP-E4+ECs cells (green) were
stained with WGA-AF594 to reveal the membrane (red) and analyzed by
confocal microscopy time-lapse imaging. The movie sequence represents
40 minutes of acquisition.
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Additional file 7: Movie 6. TnT-mediated cytoplasmic components
transfer from eGFP-E4 + ECs to ovarian cancer cells. Co-culture of
eGFP-E4 + ECs (green) and OVCAR3 were stained with WGA AF594 (red)
to reveal the membrane and analyzed by confocal microscopy time-lapse
imaging. TnT-mediated transfer of WGA stained cytoplasmic content was
observed (arrow). The movie sequence represents 1 hour of acquisition.
Additional file 8: Movie 7. GFP transfer from eGFP-E4 + ECs to MCF7
through TnTs. Co-culture of eGFP-E4 + ECs (green) and MCF7 were
stained with WGA AF594 (red) to reveal the membrane and analyzed by
confocal microscopy time-lapse imaging. GFP transfer through TnTs was
visualized (arrow). The movie sequence represents 35 minutes of
acquisition.
Additional file 9: Movie 8. Time-lapse imaging of Mitochondria
transfer through TnTs. eGFP-E4 + ECs were stained with Mitotracker
DeepRed prior to the co-culture (green). Co-culture of eGFP-E4 + ECs and
MCF7 was stained with WGA AF594 to reveal the membrane (red).
Co-culture was analyzed by confocal microscopy time-lapse imaging.
Movie is showing the mitochondria staining (green) and the WGA
staining (red) in the same time. Time-lapse imaging shows transfer of
mitochondria among cytoplasmic content through a TnT. The movie
sequence represents 2 hours of acquisition.
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